Atlas Trials

LITT and Pembrolizumab in Recurrent Brain Metastasis

Clinical trial NCT04187872 · TERMINATED

Trial details

NCT number
NCT04187872
Sponsor
University of Florida
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
MelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)Small-cell Lung CancerHead and Neck Squamous Cell CancerClassical Hodgkin LymphomaPrimary Mediastinal Large B-Cell LymphomaUrothelial CarcinomaMicrosatellite Instability-High CancerGastric CancerEsophageal CancerCervical Cancer
Start date
2020-01-10
Primary completion
2023-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.